These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. [A role of kallikrein-kinin system in gut diseases]. Zelawski W; Witalińska-Labuzek J; Stadnicki A Wiad Lek; 2005; 58(5-6):331-4. PubMed ID: 16238127 [TBL] [Abstract][Full Text] [Related]
10. Kinin B1 and B2 receptors are overexpressed in the hippocampus of humans with temporal lobe epilepsy. Perosa SR; Argañaraz GA; Goto EM; Costa LG; Konno AC; Varella PP; Santiago JF; Pesquero JB; Canzian M; Amado D; Yacubian EM; Carrete H; Centeno RS; Cavalheiro EA; Silva JA; Mazzacoratti Mda G Hippocampus; 2007; 17(1):26-33. PubMed ID: 17094085 [TBL] [Abstract][Full Text] [Related]
11. The synthesis and distribution of the kinin B1 and B2 receptors are modified in the hippocampus of rats submitted to pilocarpine model of epilepsy. Argañaraz GA; Silva JA; Perosa SR; Pessoa LG; Carvalho FF; Bascands JL; Bader M; da Silva Trindade E; Amado D; Cavalheiro EA; Pesquero JB; da Graça Naffah-Mazzacoratti M Brain Res; 2004 Apr; 1006(1):114-25. PubMed ID: 15047030 [TBL] [Abstract][Full Text] [Related]
12. Tissue kallikrein protects against pressure overload-induced cardiac hypertrophy through kinin B2 receptor and glycogen synthase kinase-3beta activation. Li HJ; Yin H; Yao YY; Shen B; Bader M; Chao L; Chao J Cardiovasc Res; 2007 Jan; 73(1):130-42. PubMed ID: 17137568 [TBL] [Abstract][Full Text] [Related]
13. Kallikrein-kinin system activation in Crohn's disease: differences in intestinal and systemic markers. Devani M; Cugno M; Vecchi M; Ferrero S; Di Berardino F; Avesani EC; de Franchis R; Colman RW Am J Gastroenterol; 2002 Aug; 97(8):2026-32. PubMed ID: 12190172 [TBL] [Abstract][Full Text] [Related]
14. Comparison of tissue kallikrein and kinin receptor expression in gastric ulcers and neoplasms. Sawant S; Snyman C; Bhoola K Int Immunopharmacol; 2001 Nov; 1(12):2063-80. PubMed ID: 11710536 [TBL] [Abstract][Full Text] [Related]
15. International union of pharmacology. XLV. Classification of the kinin receptor family: from molecular mechanisms to pathophysiological consequences. Leeb-Lundberg LM; Marceau F; Müller-Esterl W; Pettibone DJ; Zuraw BL Pharmacol Rev; 2005 Mar; 57(1):27-77. PubMed ID: 15734727 [TBL] [Abstract][Full Text] [Related]
16. Expression of the tissue kallikrein-kinin cascade in granulosa cells of the ovary. Plendl J; Snyman C; Bhoola KD Biol Chem; 2002 Dec; 383(12):1917-24. PubMed ID: 12553728 [TBL] [Abstract][Full Text] [Related]
17. Attenuated kinin release from human neutrophil elastase-pretreated kininogens by tissue and plasma kallikreins. Dulinski R; Suder P; Guevara-Lora I; Rapała-Kozik M; Potempa J; Silberring J; Imamura T; Travis J; Kozik A Biol Chem; 2003 Jun; 384(6):929-37. PubMed ID: 12887060 [TBL] [Abstract][Full Text] [Related]
18. Visualisation of tissue kallikrein and kinin receptors in oesophageal carcinoma. Dlamini Z; Raidoo D; Bhoola K Immunopharmacology; 1999 Sep; 43(2-3):303-10. PubMed ID: 10596867 [TBL] [Abstract][Full Text] [Related]
19. Expression of kinin receptors on eosinophils: comparison of asthmatic patients and healthy subjects. Bertram CM; Misso NL; Fogel-Petrovic M; Figueroa CD; Foster PS; Thompson PJ; Bhoola KD J Leukoc Biol; 2009 Mar; 85(3):544-52. PubMed ID: 19038786 [TBL] [Abstract][Full Text] [Related]
20. Kinin generation from exogenous kininogens at the surface of retinoic acid-differentiated human neuroblastoma IMR-32 cells after stimulation with interferon-γ. Guevara-Lora I; Majkucinska M; Barbasz A; Faussner A; Kozik A Peptides; 2011 Jun; 32(6):1193-200. PubMed ID: 21549779 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]